Brimonidine Tartrate
Sponsors
Bausch & Lomb Incorporated, Biogen, Galderma Brasil Ltda., Heinrich-Heine University, Duesseldorf, Wills Eye
Conditions
Alcohol-Related DisordersAldehyde Dehydrogenase DeficiencyBrimonidine TartrateChronic Persistent Vascular Facial ErythemaDry EyeFlushingGlaucoma, Open-AngleGlaucoma; Drugs
Early Phase 1
Phase 1
Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.
CompletedNCT02039765
Start: 2014-02-28End: 2014-04-30Updated: 2017-04-28
Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients
NCT05001243
Start: 2021-08-10End: 2021-09-10Target: 11Updated: 2021-08-19
Phase 2
Phase 3
Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants
CompletedNCT01959243
Start: 2014-02-22End: 2014-06-23Updated: 2019-10-23
Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness
CompletedNCT01959230
Start: 2013-11-07End: 2013-12-20Updated: 2019-10-23
Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
TerminatedNCT03591874
Start: 2018-12-23End: 2020-04-30Updated: 2022-07-06
Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)
CompletedNCT03785340
Start: 2018-12-03End: 2019-02-25Updated: 2022-07-18
Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia
CompletedNCT05270863
Start: 2022-03-30End: 2023-04-10Updated: 2024-10-15
Phase 4
Brimonidine Tartrate for the Treatment of Injection Related Erythema
WithdrawnNCT02568111
Start: 2016-02-29End: 2016-08-31Updated: 2016-04-25
A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.
CompletedNCT02856919
Start: 2016-06-13End: 2017-02-08Updated: 2017-04-06
Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study
CompletedNCT03323164
Start: 2017-07-10End: 2020-05-30Updated: 2020-12-31
Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle Glaucoma
CompletedNCT03966560
Start: 2014-01-31End: 2015-04-30Updated: 2019-05-29